Step 1 Cardiovascular
Cardiovascular is the single largest content area on USMLE Step 1 and shows up everywhere — standalone physiology questions, ECG interpretation, clinical vignettes about chest pain or dyspnea, and pharmacology questions embedded in patient scenarios. Expect the Wiggers diagram, PV loops, hemodynamic profiles, and ECG patterns to appear repeatedly, often in vignettes that require you to string together mechanism, diagnosis, and treatment in one question. For anyone reviewing high-yield cardiovascular topics for Step 1, the integrated physiology-pharmacology questions are where the most points are won or lost.
The trickiest material here lives at the intersections: knowing that RV infarct is preload-dependent changes your drug choice, knowing the LaPlace relationship explains why dilated hearts face higher afterload, knowing coronary dominance is defined by the PDA and not vessel caliber changes how you localize ischemia. Students consistently mix up preload and afterload on PV loops — afterload is the pressure the ventricle faces at the moment the aortic valve opens, not just total peripheral resistance. Isolated facts fail; the exam rewards understanding why.
USMLE cardiovascular pharmacology is deeply integrated — nitrates, antiarrhythmics, HF drugs, and antiplatelets are rarely tested in isolation. You will be handed a clinical scenario and asked to pick the right drug, avoid a contraindication, or explain a mechanism. A common trap: beta-blockers in cocaine chest pain seem reasonable for tachycardia, but they unmask alpha-1 vasoconstriction and worsen coronary spasm. Know which drugs are contraindicated in RV infarct, WPW-AFib, cocaine chest pain, and pregnancy — those specific Step 1 cardiology contraindications are tested every exam cycle.
Heart Development and Looping
Rightward D-loop versus leftward L-loop, and which heart field builds the RV and outflow tract.
- Confuses normal D-loop (rightward) with L-loop (leftward) in heart tube development
- Confuses isolated dextrocardia with situs inversus totalis regarding ciliary dyskinesia association
Cardiac Septation
Sequential formation of the interatrial septum, neural crest contributions to outflow tract septation, and defect frequencies.
- Reverses the order of septum primum and septum secundum formation
- Attributes outflow tract spiral septation to mesoderm rather than neural crest cells
Fetal Circulation and Transition
Three fetal shunts, what closes them at birth, and the pharmacology of PDA patency versus closure.
- Confuses ductus venosus destination (IVC) with direct right atrial entry
- Attributes PDA closure to rising PVR rather than increased pO2 and loss of prostaglandin tone
Coronary Arteries and Territories
Artery-to-territory mapping, dominance defined by the PDA, and how ECG leads localize infarct territory.
- Attributes anterior wall and anterior septal supply to the RCA rather than the LAD
- Defines coronary dominance by vessel size rather than by which artery supplies the posterior descending artery
Cardiac Conduction System
Pathway sequence, AV nodal delay purpose, and why inferior MI specifically causes heart block.
- Attributes AV node blood supply to the LAD rather than the RCA, missing the inferior MI–heart block link
- Misattributes AV nodal delay to ventricular conduction time rather than to completing atrial filling of the ventricles
Cardiac Cycle
Wiggers diagram phases, pressure-volume-ECG-sound relationships, and timing of all four heart sounds.
- Attributes paradoxical S2 splitting to RBBB rather than LBBB or other causes of delayed aortic closure
- Confuses the mechanism of physiologic S2 splitting — delayed P2 on inspiration, not earlier P2
Preload and Afterload
LaPlace-based definitions, PV loop locations of preload and afterload, and which drugs selectively target each.
- Confuses nitroglycerin's primary effect (preload reduction via venodilation) with afterload reduction
- Maps SVR to preload rather than afterload
Frank-Starling Relationship
Stretch-force relationship at the sarcomere level and how HFrEF shifts the curve downward, not upward.
- Confuses dobutamine's upward curve shift (increased contractility) with a rightward movement along the same curve (increased preload)
- Incorrectly shifts the HFrEF Frank-Starling curve upward rather than downward
Contractility (Inotropy)
Contractility defined independent of preload, agents that alter it, and how inotropy shifts the ESPVR leftward.
- Conflates increased preload (Frank-Starling effect) with increased contractility
- Misreads increased contractility on the PV loop as loop widening rather than leftward shift of the ESPVR
Pressure-Volume Loops
Each PV loop phase maps to a specific valve event, and characteristic morphology changes reveal altered preload, afterload, contractility, and valve disease.
- Confuses increased afterload PV loop changes (higher ESP, larger ESV, narrower loop) with a rightward EDV shift
- Confuses increased preload (rightward loop shift along same ESPVR) with a contractility change (shift of ESPVR itself)
Cardiac Output and Determinants
Fick equation, stroke volume determinants, and why TPR falls rather than rises during exercise.
- Confuses Fick CO calculation with arterial O2 content alone rather than the a-vO2 difference
- Overestimates normal EF, not recognizing that ~30–45% of EDV remains after each beat
Hemodynamic Profiles of Shock
CO, SVR, and PCWP patterns that distinguish cardiogenic, hypovolemic, distributive, and obstructive shock.
- Assumes septic shock has low CO like cardiogenic shock rather than the hallmark high CO/low SVR pattern
- Fails to use PCWP to separate cardiogenic (high PCWP) from hypovolemic (low PCWP) shock despite similar low-CO profiles
Baroreceptor and Chemoreceptor Reflexes
Afferent cranial nerve pathways and compensatory reflex responses to drug-induced blood pressure changes.
- Confuses carotid sinus (CN IX) and aortic arch (CN X) baroreceptor afferent pathways
- Predicts reflex bradycardia after vasodilator use instead of the correct reflex tachycardia
ECG Basics
Wave-interval electrical correlates, axis determination from leads I and aVF, and rate calculation from the ECG grid.
- Conflates the PR interval with atrial depolarization, missing the AV nodal delay component
- Uses lead I positivity alone to call normal axis, ignoring the required aVF assessment
Heart Sounds and Murmurs
Physiologic basis of S1–S4, systolic versus diastolic murmur timing, and how bedside maneuvers shift murmur intensity.
- Attributes both S3 and S4 to ventricular stiffness, missing that S3 reflects volume overload/dilation
- Predicts HCM murmur intensifies with increased preload, opposite to its preload-dependent obstruction mechanism
Atherosclerosis
Macrophage-derived foam cell pathogenesis, bifurcation predilection, and which arteries are relatively spared.
- Misidentifies foam cells as smooth muscle cell derivatives rather than oxidized-LDL-laden macrophages
- Assumes uniform arterial involvement, missing that bifurcations are most affected and the internal mammary artery is relatively spared
Stable Angina
Fixed stenosis threshold for symptoms, why nitrates work primarily via preload reduction, and the initial diagnostic step.
- Unaware of the ≥70% stenosis threshold required for stable angina symptoms to manifest
- Attributes nitrate anti-anginal effect solely to coronary vasodilation rather than primarily to preload/afterload reduction
ACS Classification (STEMI/NSTEMI/UA)
ECG and biomarker criteria separating STEMI, NSTEMI, and UA, including troponin rise timing.
- Allows troponin elevation in unstable angina, not recognizing that any rise defines NSTEMI
- Assumes an early negative troponin rules out MI, not accounting for the 3–6 hour rise time
ACS Reperfusion Strategy
PCI versus fibrinolysis time targets from first medical contact and absolute contraindications to lytics.
- Misidentifies the PCI time target reference point as symptom onset rather than first medical contact
- Over-applies the stroke contraindication to fibrinolysis, not recognizing the 3-month cutoff for absolute vs. relative contraindication
NSTEMI Risk Stratification and Timing
High-risk NSTEMI features that determine whether invasive timing is urgent, early, or deferred.
- Applies uniform urgent angiography timing to all NSTEMI, ignoring the risk-stratified approach that governs invasive timing
- Mandates angiography for all NSTEMI patients regardless of risk, not recognizing the conservative strategy option for low-risk cases
Right Ventricular Infarction
Proximal RCA occlusion physiology, right-sided ECG confirmation, and why nitrates are dangerous here.
- Confuses nitrate safety in RV infarction with their general ACS use
- Misses that right-sided ECG leads are required to confirm RV involvement
Post-MI Mechanical Complications
Timing, bedside murmurs, and RHC profiles distinguishing post-MI VSD, papillary rupture, and free wall rupture.
- Confuses the RHC and murmur characteristics of post-MI VSD versus papillary muscle rupture
- Misidentifies the anterolateral papillary muscle as the more vulnerable one post-MI
Post-MI Arrhythmia and ICD Indications
Early ischemic VF versus late reentrant VT, EF thresholds, and mandatory waiting period before ICD implantation.
- Incorrectly equates early post-MI VF with the late reentrant VT that drives ICD indications
- Omits the mandatory waiting period before post-MI ICD implantation
Dressler Syndrome
Autoimmune pericarditis weeks after MI, distinguished from early fibrinous pericarditis, treated with aspirin.
- Confuses the timing of Dressler syndrome with early post-MI fibrinous pericarditis
- Attributes Dressler syndrome to direct inflammation rather than autoimmune sensitization to cardiac antigens
ACS Antiplatelet and Anticoagulant Therapy
Five-drug post-STEMI discharge bundle and non-dihydropyridine CCB contraindication in reduced-EF patients.
- Fails to distinguish non-dihydropyridine CCBs as contraindicated in reduced-EF post-MI patients
- Underestimates the required duration of dual antiplatelet therapy after STEMI
Takotsubo (Stress) Cardiomyopathy
Postmenopausal women, clean coronaries with apical ballooning, and catecholamine-mediated stunning as the mechanism.
- Misidentifies the classic demographic of Takotsubo as middle-aged men rather than postmenopausal women
- Expects obstructive CAD on cath in Takotsubo, missing the hallmark of clean coronaries with apical ballooning
Vasospastic (Prinzmetal) Angina
Rest-onset chest pain from coronary vasospasm, managed with calcium channel blockers, worsened by beta-blockers.
- Confuses the rest-onset pattern of vasospastic angina with the exertional pattern of stable angina
- Applies beta-blockers to vasospastic angina without recognizing they can worsen vasospasm via unopposed alpha tone
Cocaine-Induced Chest Pain / MI
Multi-mechanism ischemia from cocaine, benzodiazepines as the first step, and beta-blockers as contraindicated.
- Applies beta-blockers to cocaine chest pain without recognizing the unopposed alpha vasoconstriction risk
- Omits benzodiazepines as the first step in cocaine chest pain management
Heart Failure Types (HFrEF / HFpEF / Right-Sided)
EF-based HFrEF versus HFpEF distinction, right-sided failure findings, and which GDMT drugs have mortality benefit only in HFrEF.
- Incorrectly extends HFrEF mortality-benefit drugs to HFpEF
- Expects pulmonary crackles in right-sided heart failure rather than systemic venous congestion with clear lungs
Acute Decompensated Heart Failure
Warm/cold by wet/dry hemodynamic profiles map directly to diuresis, vasodilation, or inotrope-based therapy.
- Applies diuresis alone to cold-and-wet ADHF without addressing the low-output component
- Unnecessarily adds inotropes to warm-and-wet ADHF, which requires diuresis alone
Cardiomyopathies (DCM / HCM / RCM)
Dilated versus HCM versus restrictive features, beta-myosin heavy chain mutation in HCM, and preload-dependent murmur mechanics.
- Knows standing worsens HCM murmur but cannot link it to the preload-cavity size mechanism
- Confuses the echocardiographic appearance of restrictive cardiomyopathy with dilated cardiomyopathy
Cardiac Amyloidosis
AL versus ATTR subtypes, low ECG voltage despite thick walls, and fat pad biopsy with Congo red as a diagnostic route.
- Conflates all cardiac amyloidosis with AL type, missing the clinically important ATTR subtype
- Expects high ECG voltage in amyloidosis due to wall thickening, when low voltage is the hallmark
Aortic Stenosis
Bicuspid valve in early-onset calcific AS, the three-symptom triad with survival implications, and valve replacement triggers.
- Attributes early-onset calcific AS to senile degeneration rather than a bicuspid aortic valve
- Misremembers which symptom in the AS triad predicts the worst survival
Mitral Regurgitation
Acute MR causes pulmonary edema in a non-compliant LA; chronic MR allows LA dilation before symptoms develop.
- Expects LA enlargement in acute MR, when the non-compliant LA instead transmits high pressure causing pulmonary edema
- Confuses the radiation pattern of the MR murmur with that of aortic stenosis
Mitral Stenosis
Rheumatic fever as the dominant cause, opening snap after S2, and mid-diastolic rumble at the apex.
- Fails to identify rheumatic heart disease as the dominant cause of mitral stenosis
- Misplaces the opening snap before S1 rather than after S2 in early diastole
Acute Rheumatic Fever / Rheumatic Heart Disease
Major versus minor Jones criteria, antibody-mediated molecular mimicry after GAS pharyngitis, and Aschoff body histology.
- Misclassifies fever and elevated inflammatory markers as major rather than minor Jones criteria
- Attributes rheumatic carditis to direct GAS invasion rather than antibody-mediated molecular mimicry
Aortic Regurgitation
Root dilation causes AR without leaflet disease; the murmur is early diastolic with bounding peripheral pulse signs.
- Overlooks aortic root dilation as a major cause of AR independent of valve leaflet pathology
- Incorrectly assigns a systolic timing to the AR murmur based on aortic valve involvement
Infective Endocarditis
Organism-to-scenario matching, painful Osler nodes versus painless Janeway lesions, and Duke criteria blood culture requirements.
- Restricts S. aureus endocarditis to IV drug users and the tricuspid valve, missing its broader clinical relevance
- Reverses the pain, morphology, and mechanism of Osler nodes versus Janeway lesions
Atrial Fibrillation — Management
Rate versus rhythm control choices, pre-cardioversion anticoagulation or TEE requirement, and CHA2DS2-VASc sex-adjusted thresholds.
- Stops anticoagulation immediately after successful cardioversion, unaware of post-cardioversion stunning
- Recommends anticoagulation at CHA2DS2-VASc ≥1 for all patients, ignoring sex-based thresholds
Supraventricular Tachycardias
AVNRT uses dual AV nodal pathways; AVRT uses an accessory tract, and AV nodal blockers are dangerous in WPW-AFib.
- Attributes an accessory bypass tract to AVNRT when it is the defining feature of AVRT
- Administers AV nodal blockers in WPW-AFib, risking acceleration of conduction through the accessory pathway
Ventricular Arrhythmias and AV Blocks
Pulseless versus stable VT management, acquired long QT causes, and ECG features distinguishing Mobitz I from Mobitz II.
- Confuses management of pulseless VT with stable VT with pulse
- Overlooks acquired causes of long QT, focusing only on congenital channelopathies
Hypertension (Primary and Secondary)
End-organ damage separates emergency from urgency, controlled 25% MAP reduction is the target, and secondary causes have specific demographic clues.
- Confuses hypertensive urgency and emergency by BP number rather than presence of end-organ damage
- Believes rapid normalization of BP is the goal in hypertensive emergency rather than a controlled 25% MAP reduction
Aortic Dissection
Tearing pain radiating to the back, Stanford A requires surgery, and anticoagulation used in ACS is contraindicated here.
- Confuses surgical urgency of Stanford Type A vs medical management of uncomplicated Type B dissection
- Confuses radiation pattern of aortic dissection pain with that of MI
Aortic Aneurysms
AAA screening targets male ever-smokers aged 65–75, with repair triggered by size and growth rate thresholds.
- Overgeneralizes AAA screening to all elderly adults rather than male ever-smokers aged 65–75
- Believes all AAAs require immediate repair rather than size- and growth-based thresholds
Peripheral Artery Disease
ABI interpretation, falsely elevated values in diabetics, Leriche triad, and cilostazol contraindication in heart failure.
- Misses falsely elevated ABI in diabetics with calcified vessels as a PAD diagnostic pitfall
- Overlooks the absolute contraindication of cilostazol in heart failure
Acute Limb Ischemia
Six Ps distinguish ischemia, paralysis and paresthesias signal late-stage, and heparin starts immediately regardless of revascularization timing.
- Confuses embolic and thrombotic causes of acute limb ischemia in presentation and management
- Misclassifies paralysis and paresthesias as early rather than late ominous signs of acute limb ischemia
Vasculitides (Large / Medium / Small Vessel)
Age and vessel size separate GCA from Takayasu; ANCA pattern and eosinophilia distinguish GPA, EGPA, and MPA.
- Confuses Takayasu arteritis and GCA by failing to distinguish their age demographics and target vessels
- Misses the asthma and eosinophilia triad that distinguishes EGPA from other ANCA-associated vasculitides
Pulmonary Hypertension
WHO group classification drives therapy — PAH-specific drugs apply only to Group 1, and RHC is the diagnostic gold standard.
- Applies Group 1 PAH-specific therapies to all forms of pulmonary hypertension regardless of WHO group
- Substitutes echocardiography for right heart catheterization as the definitive diagnostic test for PAH
Pericardial Disease (Effusion / Tamponade / Constrictive)
Tamponade gives Beck's triad and pulsus paradoxus; constrictive pericarditis gives Kussmaul sign; pericarditis gives saddle-shaped ST elevation.
- Treats pulsus paradoxus as pathognomonic for tamponade, missing other causes and exceptions
- Incorrectly attributes Kussmaul sign to cardiac tamponade rather than constrictive pericarditis
Cardiac Tumors
Left atrial myxoma arises from the fossa ovalis; rhabdomyoma in a child signals tuberous sclerosis; metastases outnumber primary tumors.
- Misses the characteristic left atrial fossa ovalis origin of cardiac myxoma
- Underestimates the relative frequency of cardiac metastases compared to primary cardiac tumors
Congenital Left-to-Right Shunts
VSD, ASD, and PDA are the three acyanotic shunts, all capable of reversing to right-to-left via Eisenmenger physiology.
- Confuses cyanotic lesions with the three classic acyanotic L-to-R shunts (VSD, ASD, PDA)
- Confuses Eisenmenger reversal (R-to-L) with progressive worsening of the original L-to-R shunt
Congenital Right-to-Left Shunts (Cyanotic)
Five T lesions cause cyanosis, TOF tet spells increase right-to-left shunting, and ductal-dependent lesions require PGE1.
- Confuses tet spell mechanism (increased RVOT obstruction → more R-to-L shunting) with a pulmonary overflow problem
- Confuses PGE1 (keeps PDA open) with indomethacin (closes PDA) in the management of ductal-dependent lesions
Aortic Coarctation
Upper extremity hypertension with lower extremity hypotension, rib 3–8 notching on CXR, and association with bicuspid aortic valve and Turner syndrome.
- Inverts the BP gradient in coarctation, placing higher pressure in the lower rather than upper extremities
- Misidentifies which ribs show notching on CXR in coarctation (ribs 3–8, not 1–2)
Shock Classification and Recognition
Hemodynamic profiles across cardiogenic, hypovolemic, distributive, and obstructive shock differ by SVR and CO; obstructive shock requires source control, not just fluids or vasopressors.
- Confuses distributive shock hemodynamics (low SVR, high CO) with the high-SVR pattern of cardiogenic or hypovolemic shock
- Applies fluid-resuscitation logic of hypovolemic shock to cardiogenic shock, risking pulmonary edema
Syncope (Cardiac, Vasovagal, Orthostatic)
Exertional syncope without prodrome flags a cardiac cause; vasovagal has prodrome; orthostatic requires quantitative BP-drop criteria.
- Misclassifies exertional syncope as vasovagal rather than recognizing it as a cardiac red flag
- Diagnoses orthostatic syncope by symptoms alone without applying the quantitative BP-drop criteria
Adrenergic Receptors and Agonists
Receptor subtype locations, epinephrine's dose-dependent selectivity shift, and baroreceptor reflex responses to agonists and vasodilators.
- Ignores dose-dependent receptor selectivity of epinephrine (low dose β2 vasodilation vs. high dose α1 vasoconstriction)
- Accepts 'renal-dose dopamine' as evidence-based renoprotection when clinical trials do not support this
Cholinergic Receptors and Agents
Cardiac slowing is M2-mediated, not nicotinic, and the two toxidromes are separated by wet-versus-dry and miosis-versus-mydriasis.
- Attributes cardiac effects of ACh to nicotinic rather than M2 muscarinic receptors
- Confuses anticholinergic toxidrome (dry, mydriasis) with cholinergic toxidrome (wet, miosis)
Antihypertensives Overview
Comorbidity and demographics drive drug choice; ACEi is teratogenic in pregnancy; beta-blocker precedes nitroprusside in dissection.
- Selects ACE inhibitors for hypertension in pregnancy, missing their absolute teratogenic contraindication
- Uses nitroprusside alone for dissection, missing the requirement for beta-blocker first to prevent reflex tachycardia
Nitrates
Preferential venodilation reduces preload via NO/cGMP, PDE5 inhibitor co-use is an absolute contraindication, and tolerance requires a nitrate-free interval.
- Misidentifies nitrates as primarily afterload reducers rather than preload reducers via preferential venodilation
- Fails to recognize the absolute contraindication of nitrates with PDE5 inhibitors due to synergistic cGMP-mediated hypotension
Antiarrhythmics (Class I-IV + Others)
Vaughan Williams class mechanisms, amiodarone's multi-organ toxicity, CAST trial limits on Class Ic use, and adenosine's role in SVT.
- Selects Class Ia over Class Ib for ischemic arrhythmias, missing Ib's selective affinity for inactivated channels in depolarized tissue
- Inverts the effect of ischemic depolarization on Na+ channel state, thinking inactivated-channel proportion decreases rather than increases
Heart Failure Pharmacotherapy
Four GDMT pillars for HFrEF, ARNI requires ACEi washout to prevent angioedema, and hydralazine/nitrates provide mortality benefit in Black patients.
- Confuses the ARNI washout rationale (angioedema via dual bradykinin blockade) with a hemodynamic concern
- Selects digoxin instead of hydralazine/nitrates for mortality benefit in Black HFrEF patients, confusing symptom relief with survival benefit
Antiplatelets and Anticoagulants
Aspirin blocks TXA2, P2Y12 agents block ADP, and each anticoagulant has a specific reversal agent including andexanet alfa for Xa inhibitors.
- Confuses aspirin's COX-1/TXA2 mechanism with the ADP/P2Y12 mechanism of clopidogrel
- Overlooks warfarin's delayed onset and early hypercoagulable state, missing the need for heparin bridging in acute thrombosis
Lipid-Lowering Agents
Statins upregulate LDL receptors, myopathy is dose- and CYP3A4-dependent, and niacin raises HDL more than any other agent.
- Misses the compensatory LDL receptor upregulation as the primary mechanism by which statins lower plasma LDL
- Confuses statin myopathy as idiosyncratic/allergic rather than dose-dependent and CYP3A4 interaction-mediated
Vasopressors and Inotropes
Norepinephrine is first-line for septic shock; dobutamine activates beta-1 directly while milrinone inhibits PDE-3 downstream; cardiogenic shock needs inotropy.
- Selects dopamine over norepinephrine as first-line for septic shock based on a misconception about renal-dose dopamine benefit
- Conflates dobutamine and milrinone as beta-1 agonists, missing that milrinone acts downstream via PDE-3 inhibition
See how your Anki deck covers Cardiovascular.
Upload your deck for a free audit →